O
VOR icon

OrbiMed’s Vor Biopharma VOR Stock Holding History

OrbiMed’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,590
Closed -$445 – 133
2022
Q3 		$445 Sell
5,590
-36,077
-87% -$3.55M 0.01% 130
2022
Q2 		$4.14K Hold
41,667
– – 0.08% 115
2022
Q1 		$5.03M Hold
41,667
– – 0.08% 122
2021
Q4 		$9.68M Hold
41,667
– – 0.12% 118
2021
Q3 		$13.1M Hold
41,667
– – 0.14% 116
2021
Q2 		$15.5M Hold
41,667
– – 0.16% 106
2021
Q1 		$35.9M Buy
+41,667
New +$35.3M 0.34% 74

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return